Catalyst Healthcare Consulting President Nancy Bradish Myers, JD, will speak at Windhover’s FDA/CMS Summit as part of a panel on drug safety, entitled “Equal Voice: The Drug Safety Side of FDA.” The panel will be led by Gerald Dal Pan, MD, Director of FDA’s Office of Surveillance and Epidemiology.
Further information is available at